| Mrs Lucy Carter Ault, | |
|
1400 Griffin Mill Rd, Easley, SC 29640-6929 | |
| (864) 397-1059 | |
| (864) 859-1779 |
| Full Name | Mrs Lucy Carter Ault |
|---|---|
| Gender | Female |
| Speciality | Counselor - School |
| Location | 1400 Griffin Mill Rd, Easley, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316383680 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YS0200X | Counselor - School | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Lucy Carter Ault, 1400 Griffin Mill Rd, Easley, SC 29640-6929 Ph: (864) 397-1059 | Mrs Lucy Carter Ault, 1400 Griffin Mill Rd, Easley, SC 29640-6929 Ph: (864) 397-1059 |
News Archive
Until now, patients with heart failure with preserved ejection fraction – the most common type of heart failure in the elderly – have had no access to evidenced-based treatments. For the first time, a large clinical trial led by Prof. Dr. Stefan Anker from Charité – Universitätsmedizin Berlin has identified a drug which has a distinctly positive effect on prognosis. In patients affected by this type of heart failure, the drug – empagliflozin – reduces the risk of hospitalization or cardiovascular death by 21 percent. The results of this research have been published in the New England Journal of Medicine.
PanGenex Corporation, a global nutraceutical and dietary supplement manufacturer and marketer, announced today that it has finalized a strategic partnership with BulovaTech Labs, Inc., ("LABS"), a wholly-owned subsidiary of Bulova Technologies Group Inc.
Neoprobe Corporation, a diversified developer of innovative oncology and surgical diagnostic and treatment products, today announced that it recently met with the United States Food and Drug Administration to review the clinical trial results of a Phase 3 investigational new drug, Lymphoseek®.
Researchers at Montana State University have developed six new biomedical technologies that could have applications for treating antibiotic resistant infections, fungal infections and viral infections; boosting humans' innate immunity and improving scientists' ability to study such compounds. The technologies are available for licensing to interested companies and entrepreneurs.
› Verified 8 days ago
David C Shorter, REV. Counselor Medicare: Not Enrolled in Medicare Practice Location: 312 E 1st Ave, Suite B, Easley, SC 29640 Phone: 864-850-1777 | |
Matthew Davidson, Counselor Medicare: Not Enrolled in Medicare Practice Location: 405a E 1st Ave, Easley, SC 29640 Phone: 864-644-8251 Fax: 864-644-8253 | |
Mr. Christopher D Glover, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1400 Griffin Mill Rd, Easley, SC 29640 Phone: 864-397-1059 Fax: 864-859-1779 | |
Alexis Ellen Richardson, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 300 Couch Ln, Easley, SC 29642 Phone: 864-553-6100 | |
Erica Adams, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 405a E 1st Ave, Easley, SC 29640 Phone: 864-644-8251 Fax: 868-644-8253 | |
Barbara E Chapman, M.A. Counselor Medicare: Not Enrolled in Medicare Practice Location: 202 Elljean Rd, Easley, SC 29640 Phone: 864-616-7908 | |
Ginger Chastain, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1400 Griffin Mill Rd, Easley, SC 29640 Phone: 864-397-1059 Fax: 864-859-1779 |